Skip to main content
Signal8

ROBINS CHAD M

SEC insider (Form 3/4/5 filer). CIK 0001780649. CEO and Chairman at Adaptive Biotechnologies Corp (ADPT). 38 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in SEATTLE, WA.

Companies ROBINS CHAD M has filed insider reports for

  • Adaptive Biotechnologies Corp (ADPT): Director, Officer, CEO and Chairman
ROBINS CHAD M profile photo

ROBINS CHAD M

CIK: 0001780649

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)27 (71.1%)

Position reduction

Option Exercises (M)7 (18.4%)

Derivative conversions

Awards (A)4 (10.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Adaptive Biotechnologies Corp logo
ADPT

Adaptive Biotechnologies Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (38 total)

  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 18, 2026
    Sale
    Direct
    278.5K shares at avg. $24.48$6.8M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 18, 2026
    Exercise
    Direct
    278.7K shares at avg. $6.55$1.8M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 18, 2026
    Sale
    Direct
    204 shares at avg. $25.14$5K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 17, 2026
    Sale
    Direct
    2.5K shares at avg. $25.57$65K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 17, 2026
    Exercise
    Direct
    321.3K shares at avg. $6.55$2.1M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Aug 17, 2026
    Sale
    Direct
    318.8K shares at avg. $25.08$8.0M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Apr 8, 2026
    Sale
    Direct
    37.3K shares at avg. $15.19$566K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Apr 6, 2026
    Sale
    Direct
    83.3K shares at avg. $14.41$1.2M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 11, 2026
    Sale
    Direct
    140.6K shares at avg. $13.17$1.9M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 11, 2026
    Sale
    Direct
    329.6K shares at avg. $13.17$4.3M

1-10 of 38